About this policy
CMS evidence review | evidence_type=MEDCAC Meeting | record_type=medcac_meeting | document_id=47 | meeting_date=2009-02-25
Coverage indications
Genetic tests have been developed for a growing number of diseases. Many tests are currently marketed for clinical uses, but the evidence base used to support these uses is not yet well developed. CMS wishes to obtain the MEDCAC’s recommendation regarding the desirable characteristics of evidence that could be used by the Medicare program to determine whether genetic testing as a laboratory diagnostic service improves health outcomes. The Secretary’s Advisory Committee on Genetics, Health and Society (SACGHS) has defined genetic testing as “…any test performed using molecular biology methods to test DNA or RNA, including germline, heritable, and acquired somatic variations.”
Codes in this policy
Code numbers and each code’s status as the policy records it. CPT code descriptions are left out of this page, as are the passages that cite CPT codes; the official document has them.
Backwork has no codes on record for this policy. Check the source.